Advertisement
Advertisement
U.S. markets close in 1 hour 41 minutes
Advertisement
Advertisement
Advertisement
Advertisement

Arrowhead Pharmaceuticals, Inc. (ARWR)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
30.50-1.06 (-3.36%)
As of 02:18PM EST. Market open.
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bullishpattern detected
Short-term KST

Short-term KST

Previous Close31.56
Open31.34
Bid30.30 x 1200
Ask30.37 x 800
Day's Range30.19 - 31.35
52 Week Range26.81 - 73.03
Volume437,353
Avg. Volume870,422
Market Cap3.233B
Beta (5Y Monthly)1.36
PE Ratio (TTM)N/A
EPS (TTM)-1.08
Earnings DateJan 31, 2023 - Feb 06, 2023
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est69.69
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued

Subscribe to Yahoo Finance Plus to view Fair Value for ARWR

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Arrowhead Pharmaceuticals, Inc.
    ARWR: Raising target price to $34.00ARROWHEAD PHARMACEUTICALS IN has an Investment Rating of HOLD; a target price of $34.000000; an Industry Subrating of High; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Medium; a Growth Subrating of Medium; and a Value Subrating of High.
    Rating
    Fair Value
    Economic Moat
    2 days agoArgus Research
View more
Advertisement
Advertisement